Inflammatory Bowel Diseases: From Bench to Bedside : Proceedings of the Falk Symposium No. 96 (Part IV of the Gastroenterology Symposia 1996) Held in Freiburg-im-Breisgau, Germany, October 30-November 1, 1996T. Andus |
From inside the book
Results 1-3 of 87
Page 137
... specific mediator or blockage of a specific receptor may be of value . However , it should be consi- dered that a breakthrough in the management of IBD , using a specific inhibitor or receptor blocker , is expected only if the mediator ...
... specific mediator or blockage of a specific receptor may be of value . However , it should be consi- dered that a breakthrough in the management of IBD , using a specific inhibitor or receptor blocker , is expected only if the mediator ...
Page 161
... specific effects of TGF - ẞ on collagen synthesis by human intestinal mesenchymal cells are not understood . One level of control may be achieved through differential expres- sion of TGF - ẞ receptor isoforms through which TGF - B , may ...
... specific effects of TGF - ẞ on collagen synthesis by human intestinal mesenchymal cells are not understood . One level of control may be achieved through differential expres- sion of TGF - ẞ receptor isoforms through which TGF - B , may ...
Page 325
... specific T cell activation by inhibiting the antigen presentation and acces- sory cell functions of antigen - presenting cells ( APC ) , which are associated with down - regulation of cell surface molecules involved in antigen ...
... specific T cell activation by inhibiting the antigen presentation and acces- sory cell functions of antigen - presenting cells ( APC ) , which are associated with down - regulation of cell surface molecules involved in antigen ...
Contents
new data | 5 |
Current and future parameters for stratification | 13 |
Genetic and chemical models of inflammatory bowel | 21 |
Copyright | |
44 other sections not shown
Common terms and phrases
acid active Crohn's disease acute adhesion molecules antibody antigens associated azathioprine bacterial budesonide cancer CD4+ T cells chronic Clin clinical colectomy colitis and Crohn's collagen colonic controlled trial corticosteroids Crohn's disease cyclosporine cytokines disease activity dose drugs dysplasia effect elemental diet endoscopic enemas expression fibroblasts fistulae function Gastroenterol Gastroenterology gastrointestinal gene genetic growth factor human IFN-y ileal ileostomy ileum immune Immunol increased induced inflammation inflammatory bowel disease inhibition integrins interleukin intestinal epithelial cells intestinal inflammation lamina propria lesions levels lymphocytes macrophages mast cells measles mediators mesalazine metabolism metronidazole mice mucosal normal oral pathogenesis patients with Crohn's patients with inflammatory patients with ulcerative peptide placebo pouch pouchitis prednisolone proctocolectomy production protein recent receptor recurrence relapse remission resection response risk role short bowel syndrome small bowel small intestine steroid stimulation studies sulphasalazine surgery therapeutic therapy tissue TNF-a treatment tumor necrosis ulcerative colitis